Category: Peptides Research
Research articles and educational content on peptides and longevity compounds, authored and reviewed by Dr. James, a board-certified neurosurgeon trained at Yale University, and Dr. Tom, a licensed pharmacist. All content is for research and educational purposes only.
-
Semax: Neuropeptide Research and Cognitive Biology — What the Science Reveals
The ACTH(4-7) fragment that forms the structural basis of Semax has been studied for decades in Russian neurological research, but it has only recently attracted broader attention in Western peptide science. What sets it apart from other cognitive research compounds is its documented effect on BDNF — brain-derived neurotrophic factor — which plays a central…
-
Epithalon and Telomere Research: What Science Reveals About This Tetrapeptide Bioregulator
Telomerase activation has been a target of longevity research for over three decades, but few compounds have been studied in this context as specifically as Epithalon. This tetrapeptide — Ala-Glu-Asp-Gly — was originally isolated from the bovine pineal gland by Vladimir Khavinson’s group in St. Petersburg, and the research program that followed is one of…
-
GHK-Cu Copper Peptide and Skin Biology Research: What Scientists Have Found
GHK-Cu Copper Peptide and Skin Biology Research: What Scientists Have Found GHK-Cu has gone from an obscure biochemistry finding to one of the most studied tripeptides in dermatological research — and the science behind its effects is more sophisticated than most people realize. As someone who works with tissue biology daily in my neurosurgical practice,…
-
GHK-Cu: What Research Reveals About Copper Peptide and Tissue Biology
Most peptides interact with a single receptor or pathway. GHK-Cu does something considerably more unusual: research by Loren Pickart and others has demonstrated that this copper-binding tripeptide modulates the expression of over 4,000 human genes, roughly a third of the human genome, by interacting with chromatin remodeling machinery rather than a classical receptor. That breadth…
-
Retatrutide: Inside the Research on a Triple Hormone Receptor Agonist
The GLP-1 receptor agonist class transformed metabolic medicine, but the limiting factor was always the ceiling on weight reduction and glycemic control achievable through a single receptor. Retatrutide was designed to test whether adding GIP and glucagon receptor co-agonism could push past that ceiling, and the phase 2 data published in the New England Journal…
-
PT-141 and Melanocortin Receptor Research: What the Science Reveals
The melanocortin system is one of the more underappreciated regulatory networks in neuroscience, governing not just pigmentation but energy homeostasis, inflammation, and — through hypothalamic MC3R and MC4R — aspects of autonomic function that researchers have only begun to characterize fully. PT-141 (bremelanotide) enters this system through the same receptor axis used by alpha-MSH, but…
-
NAD+ and Mitochondrial Function: What the Research Reveals
NAD+ sits at the intersection of four distinct biological processes that matter enormously for cellular longevity: it is a cofactor for the sirtuin deacetylases, a substrate for PARP-mediated DNA repair, a regulator of the circadian clock through NAMPT, and the central electron carrier in oxidative phosphorylation. What makes the research compelling is not any one…
-
TB-500 (Thymosin Beta-4): Understanding Its Role in Cellular Recovery Research
Cell migration is a prerequisite for tissue repair, and most healing peptides influence it indirectly — through growth factor upregulation, inflammatory modulation, or angiogenesis. TB-500 approaches this problem differently. The active region of Thymosin Beta-4, which TB-500 replicates, binds G-actin and sequesters it from polymerization, shifting the equilibrium of the actin cytoskeleton in a way…
-
Tirzepatide vs Semaglutide: What the Current Research Shows
The SURPASS and SURMOUNT trial data on tirzepatide arrived at a moment when GLP-1 monotherapy was already considered a major therapeutic advance, and the weight loss numbers from tirzepatide’s phase 3 program — mean reductions of 20-22% of body weight in the highest dose arms — were substantially larger than anything semaglutide had produced. The…
-
BPC-157 Peptide: Tissue Repair Mechanisms in Research Models | BLL Peptides
A scientific review of BPC-157, a synthetic pentadecapeptide studied in preclinical research models for its proposed roles in tissue repair, angiogenesis, and cellular regeneration. Written by Dr. James for research purposes only.
